| Age |
0.9815 |
0.001 |
0.9790 |
0.9840 |
| Sex |
| Male |
Reference |
| Female |
0.9583 |
0.166 |
0.9023 |
1.0178 |
| Race |
| White |
Reference |
| Black |
0.9783 |
0.680 |
0.8815 |
1.0858 |
| American Indian, Aleutian or Eskimo |
1.1315 |
0.655 |
0.6584 |
1.9446 |
| Asian |
0.8965 |
0.299 |
0.7296 |
1.1017 |
| Pacific Islander |
0.9725 |
0.882 |
0.6727 |
1.4060 |
| Other |
0.7649 |
0.119 |
0.5460 |
1.0717 |
| Unknown |
0.8063 |
0.079 |
0.6342 |
1.0253 |
| Facility Type |
| Community Cancer Program |
Reference |
| Comprehensive Community Cancer Program |
1.1402 |
0.047 |
1.0019 |
1.2976 |
| Academic/Research Program |
1.3665 |
0.000 |
1.2042 |
1.5508 |
| Integrated Network Cancer Program |
0.9659 |
0.679 |
0.8195 |
1.1385 |
| Unknown |
0.9747 |
0.769 |
0.8209 |
1.1572 |
| Year of Diagnosis |
1.0022 |
0.798 |
0.9855 |
1.0192 |
| Histology |
| Sarcoma, NOS |
Reference |
| Ewing's sarcoma |
0.7723 |
0.14 |
0.5477 |
1.0889 |
| Epithelioid sarcoma |
0.9648 |
0.835 |
0.6883 |
1.3524 |
| High grade undifferentiate pleomorphic sarcoma |
1.0420 |
0.459 |
0.9346 |
1.1617 |
| Fibrosarcoma |
0.8749 |
0.029 |
0.7763 |
0.9861 |
| Solitary fibrous tumor |
0.7840 |
0.182 |
0.5484 |
1.1209 |
| Dermatofibrosarcoma protuberans |
0.9739 |
0.869 |
0.7109 |
1.3341 |
| Liposarcoma, NOS |
0.5138 |
0.000 |
0.4422 |
0.5969 |
| Liposarcoma, well differentiated |
0.4023 |
0.000 |
0.3495 |
0.4630 |
| Myxoid liposarcoma |
1.0372 |
0.660 |
0.8814 |
1.2207 |
| Round cell liposarcoma |
1.3610 |
0.181 |
0.8668 |
2.1372 |
| Pleomorphic liposarcoma |
0.9586 |
0.694 |
0.7767 |
1.1831 |
| Dedifferentiated liposarcoma |
0.3888 |
0.000 |
0.3324 |
0.4547 |
| Leiomyosarcoma |
1.1024 |
0.082 |
0.9876 |
1.2306 |
| Vascular sarcoma |
0.9389 |
0.496 |
0.7829 |
1.1258 |
| Rhabdomyosarcoma |
1.0013 |
0.993 |
0.7444 |
1.3470 |
| Synovial sarcoma |
1.0419 |
0.676 |
0.8593 |
1.2632 |
| Clear cell sarcoma |
0.9419 |
0.852 |
0.5019 |
1.7675 |
| Chondrosarcoma |
1.0734 |
0.585 |
0.8323 |
1.3843 |
| Malignant giant cell tumor |
1.1670 |
0.754 |
0.4440 |
3.0672 |
| Malignant peripheral nerve sheath tumor |
0.6464 |
0.000 |
0.5481 |
0.7624 |
| Alveolar soft part sarcoma |
0.8970 |
0.843 |
0.3058 |
2.6309 |
| Grade |
| Grade 1 |
Reference |
| Grade 2 |
0.8779 |
0.018 |
0.7879 |
0.9781 |
| Grade 3 |
1.0651 |
0.231 |
0.9608 |
1.1808 |
| Grade 4 |
1.0612 |
0.294 |
0.9498 |
1.1857 |
| Tumor Size |
0.9992 |
0.000 |
0.9990 |
0.9994 |
| Charlson-Deyo Score |
| no comorbid condition |
Reference |
| 1 comorbid condition |
0.9174 |
0.042 |
0.8441 |
0.9971 |
| >1 comorbid condition |
0.9879 |
0.884 |
0.8391 |
1.1631 |
| Radiation-Surgery Sequence |
| No radiation therapy |
Reference |
| Radiation therapy before surgery |
1.8257 |
0.000 |
1.6075 |
2.0734 |
| Radiation therapy after surgery |
0.6746 |
0.000 |
0.6321 |
0.7200 |
| Systemic Surgery Sequence |
| No systemic therapy |
Reference |
| Systemic therapy before surgery |
1.0583 |
0.530 |
0.8867 |
1.2632 |
| Systemic therapy after surgery |
0.5581 |
0.000 |
0.4957 |
0.6284 |
| Systemic therapy before and after surgery |
1.0705 |
0.699 |
0.7583 |
1.5111 |
| Systemic therapy given, sequence unknown |
1.1080 |
0.535 |
0.8013 |
1.5322 |
| Unknown |
1.0106 |
0.849 |
0.9065 |
1.1266 |
